Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

ETFMG Prime Mobile Payments ETF (IPAY)

ETFMG Prime Mobile Payments ETF (IPAY)
N/A x N/A 70.00 x 1
Post-market by (Cboe BZX)
57.64 -0.33 (-0.57%) 02/24/25 [NYSE Arca]
N/A x N/A 70.00 x 1
Post-market 57.64 unch (unch) 20:00 ET
News & Headlines for Mon, Feb 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Is Wall Street Bullish or Bearish on Global Payments Stock?

Global Payments has considerably underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

GPN : 103.84 (+0.64%)
$SPX : 5,983.25 (-0.50%)
IPAY : 57.64 (-0.57%)
Visa Stock Outlook: Is Wall Street Bullish or Bearish?

Despite underperforming other payment stocks over the past year, analysts remain strongly bullish on Visa’s prospects.

C : 78.54 (-1.39%)
$SPX : 5,983.25 (-0.50%)
V : 349.86 (+0.38%)
IPAY : 57.64 (-0.57%)
Top 4 Sectors & Their ETFs of Past Three Months

Wall Street offered a solid performance in the past three months. The S&P 500-based exchange-traded fund (ETF) SPY added 4%, QQQ returned 7% and DIA added 1.8% in the past three months (as of Jan. 7,...

QQQ : 519.87 (-1.18%)
DAPP : 12.71 (-6.13%)
SIXG : 48.11 (-1.88%)
SPY : 597.21 (-0.46%)
DIA : 434.53 (+0.09%)
IPAY : 57.64 (-0.57%)
NERD : 22.80 (-0.83%)
Mastercard Completes Acquisition Of Threat Intelligence Firm Recorded Future: Retail Sentiment Score Improves

Mastercard believes adding Recorded Future’s AI-driven threat intelligence capabilities to its cybersecurity services, identity solutions and real-time fraud scoring will enable the firm to better support...

XLF : 50.97 (+0.43%)
MA : 559.00 (+0.27%)
IPAY : 57.64 (-0.57%)
How Is Corpay's Stock Performance Compared to Other Digital Payments Stocks?

Corpay has underperformed the digital payments industry over the past year, but analysts are moderately optimistic about the stock’s prospects.

GPN : 103.84 (+0.64%)
CPAY : 361.23 (-0.72%)
IPAY : 57.64 (-0.57%)
5 ETFs for Smart Holiday Season Investing

The holiday season started on a strong note with online and in-store shopping surging on early sales promotions from retailers. The skyrocketing stock market backed by the Trump bump, Fed rate cuts and...

PSCD : 106.44 (+0.50%)
ONLN : 47.62 (-2.54%)
XRT : 75.53 (+0.32%)
IPAY : 57.64 (-0.57%)
IBUY : 68.84 (-0.37%)
ETFs Set to Soar on Solid Thanksgiving Weekend Sales

Americans spent considerably this year over the five-day Thanksgiving weekend, lured by free shipping offers, a limited sale or promotion, or a positive review that helped to convince most shoppers to...

PSCD : 106.44 (+0.50%)
ONLN : 47.62 (-2.54%)
XRT : 75.53 (+0.32%)
IPAY : 57.64 (-0.57%)
IBUY : 68.84 (-0.37%)
What Are Wall Street Analysts' Target Price for American Express Stock?

Although American Express has significantly outpaced the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

$SPX : 5,983.25 (-0.50%)
AXP : 295.53 (+0.04%)
AXP : 295.53 (+0.04%)
IPAY : 57.64 (-0.57%)
Corpay Stock: Analyst Estimates & Ratings

Corpay has underperformed the broader market over the past year, yet analysts remain bullish on the stock’s prospects.

CPAY : 361.23 (-0.72%)
$SPX : 5,983.25 (-0.50%)
$SPX : 5,983.25 (-0.50%)
IPAY : 57.64 (-0.57%)
CPAY : 361.23 (-0.72%)
JPM : 261.34 (-1.10%)
Tech ETFs That Won Amid NVIDIA-Led Tech Rout

The technology ETF The Technology Select Sector SPDR Fund XLK lost 0.9% on Aug. 29, 2024, although the Dow Jones Industrial Average closed at a new all-time high, marking its third record this week. The...

NVDA : 130.28 (-3.09%)
XLK : 231.51 (-1.43%)
XSW : 181.78 (-1.46%)
IPAY : 57.64 (-0.57%)
DTEC : 46.77 (-0.84%)
CLOU : 23.93 (-1.36%)
BPAY : 26.62 (-0.47%)
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope

/PRNewswire/ -- USA News Group - Earlier this year, the US White House requested over $2.8 billion in funding from Congress for their "Cancer Moonshot"...

ONC.TO : 1.02 (-0.97%)
ONCY : 0.7138 (-1.63%)
IMGN : 31.23 (unch)
MRK : 91.27 (+1.98%)
AZN : 74.69 (+0.63%)
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – September 20, 2023 – USA News Group  –  Earlier this year, the US White House requested over $2.8 billion in funding from...

LLY : 881.40 (+0.88%)
RY : 118.57 (-0.26%)
RY.TO : 169.14 (-0.05%)
ONCY : 0.7138 (-1.63%)
ONC.TO : 1.02 (-0.97%)
IMGN : 31.23 (unch)
AZN : 74.69 (+0.63%)
MRK : 91.27 (+1.98%)
Markets Today: Stocks Push Higher on Strength in China and Europe

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.17%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.18% at a 1-week high. Stock indexes this morning are moderately...

ESH25 : 6,012.75 (+0.20%)
NQH25 : 21,431.00 (+0.05%)
COP : 98.82 (+0.90%)
DVN : 37.31 (-0.48%)
FANG : 155.23 (-0.57%)
XOM : 111.27 (+0.52%)
MRO : 28.55 (-1.28%)
SLB : 41.53 (-0.50%)
VLO : 135.06 (+0.24%)
MET : 81.21 (+0.25%)
PLTR : 90.68 (-10.53%)
ADBE : 444.42 (+0.02%)
ImmunoGen: Q2 Earnings Snapshot

ImmunoGen: Q2 Earnings Snapshot

IMGN : 31.23 (unch)
ImmunoBiochem Announces Multi-Target License and Option Agreement with ImmunoGen to Develop Next-Generation Antibody-Drug Conjugates

/PRNewswire/ - ImmunoBiochem Corporation, a privately-held biopharmaceutical company focused on the discovery of unique tumor targets and development of novel...

IMGN : 31.23 (unch)
MoonLake Immunotherapeutics Makes a Moonshot on Trials

Clinical-stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive clinical trial results.

MLTX : 40.96 (-3.24%)
IMGN : 31.23 (unch)
Five Top Companies Fighting for the Treatment of Metastatic Breast Cancer

A significant medical breakthrough is needed in the fight against metastatic breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of...

LLY : 881.40 (+0.88%)
PBYI : 2.89 (-0.52%)
GILD : 111.03 (+0.98%)
IMGN : 31.23 (unch)
BCTX : 4.54 (+2.71%)
BCT.TO : 6.45 (+1.90%)
ImmunoGen Stock Continues to Defy Gravity on Phase 2 Trials

ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles t

IMGN : 31.23 (unch)
C : 78.54 (-1.39%)
GILD : 111.03 (+0.98%)
LEA : 97.02 (+0.64%)
PFE : 26.65 (+1.33%)
SGEN : 228.74 (-0.07%)
AZN : 74.69 (+0.63%)
Stocks Settle Mixed on Weak U.S. Economic Reports

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.205%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.59%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed...

$SPX : 5,983.25 (-0.50%)
SPY : 597.21 (-0.46%)
$DOWI : 43,461.21 (+0.08%)
DIA : 434.53 (+0.09%)
$IUXX : 21,352.08 (-1.21%)
QQQ : 519.87 (-1.18%)
INTC : 24.27 (-2.41%)
GFS : 41.52 (-2.14%)
MRVL : 97.91 (-5.68%)
QCOM : 161.10 (-2.62%)
MCHP : 60.83 (-0.39%)
MU : 95.41 (-3.47%)
Stocks Slip in Afternoon Trade

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.2%. After...

$SPX : 5,983.25 (-0.50%)
SPY : 597.21 (-0.46%)
$DOWI : 43,461.21 (+0.08%)
DIA : 434.53 (+0.09%)
$IUXX : 21,352.08 (-1.21%)
QQQ : 519.87 (-1.18%)
DVN : 37.31 (-0.48%)
MRO : 28.55 (-1.28%)
FANG : 155.23 (-0.57%)
CVX : 157.89 (+0.62%)
COP : 98.82 (+0.90%)
XOM : 111.27 (+0.52%)
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope

/PRNewswire/ -- USA News Group - Earlier this year, the US White House requested over $2.8 billion in funding from Congress for their "Cancer Moonshot"...

ONC.TO : 1.02 (-0.97%)
ONCY : 0.7138 (-1.63%)
IMGN : 31.23 (unch)
MRK : 91.27 (+1.98%)
AZN : 74.69 (+0.63%)
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – September 20, 2023 – USA News Group  –  Earlier this year, the US White House requested over $2.8 billion in funding from...

LLY : 881.40 (+0.88%)
RY : 118.57 (-0.26%)
RY.TO : 169.14 (-0.05%)
ONCY : 0.7138 (-1.63%)
ONC.TO : 1.02 (-0.97%)
IMGN : 31.23 (unch)
AZN : 74.69 (+0.63%)
MRK : 91.27 (+1.98%)
Markets Today: Stocks Push Higher on Strength in China and Europe

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.17%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.18% at a 1-week high. Stock indexes this morning are moderately...

ESH25 : 6,012.75 (+0.20%)
NQH25 : 21,431.00 (+0.05%)
COP : 98.82 (+0.90%)
DVN : 37.31 (-0.48%)
FANG : 155.23 (-0.57%)
XOM : 111.27 (+0.52%)
MRO : 28.55 (-1.28%)
SLB : 41.53 (-0.50%)
VLO : 135.06 (+0.24%)
MET : 81.21 (+0.25%)
PLTR : 90.68 (-10.53%)
ADBE : 444.42 (+0.02%)
ImmunoGen: Q2 Earnings Snapshot

ImmunoGen: Q2 Earnings Snapshot

IMGN : 31.23 (unch)
ImmunoBiochem Announces Multi-Target License and Option Agreement with ImmunoGen to Develop Next-Generation Antibody-Drug Conjugates

/PRNewswire/ - ImmunoBiochem Corporation, a privately-held biopharmaceutical company focused on the discovery of unique tumor targets and development of novel...

IMGN : 31.23 (unch)
MoonLake Immunotherapeutics Makes a Moonshot on Trials

Clinical-stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive clinical trial results.

MLTX : 40.96 (-3.24%)
IMGN : 31.23 (unch)
Five Top Companies Fighting for the Treatment of Metastatic Breast Cancer

A significant medical breakthrough is needed in the fight against metastatic breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of...

LLY : 881.40 (+0.88%)
PBYI : 2.89 (-0.52%)
GILD : 111.03 (+0.98%)
IMGN : 31.23 (unch)
BCTX : 4.54 (+2.71%)
BCT.TO : 6.45 (+1.90%)
ImmunoGen Stock Continues to Defy Gravity on Phase 2 Trials

ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles t

IMGN : 31.23 (unch)
C : 78.54 (-1.39%)
GILD : 111.03 (+0.98%)
LEA : 97.02 (+0.64%)
PFE : 26.65 (+1.33%)
SGEN : 228.74 (-0.07%)
AZN : 74.69 (+0.63%)
Stocks Settle Mixed on Weak U.S. Economic Reports

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.205%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.59%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed...

$SPX : 5,983.25 (-0.50%)
SPY : 597.21 (-0.46%)
$DOWI : 43,461.21 (+0.08%)
DIA : 434.53 (+0.09%)
$IUXX : 21,352.08 (-1.21%)
QQQ : 519.87 (-1.18%)
INTC : 24.27 (-2.41%)
GFS : 41.52 (-2.14%)
MRVL : 97.91 (-5.68%)
QCOM : 161.10 (-2.62%)
MCHP : 60.83 (-0.39%)
MU : 95.41 (-3.47%)
Stocks Slip in Afternoon Trade

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.2%. After...

$SPX : 5,983.25 (-0.50%)
SPY : 597.21 (-0.46%)
$DOWI : 43,461.21 (+0.08%)
DIA : 434.53 (+0.09%)
$IUXX : 21,352.08 (-1.21%)
QQQ : 519.87 (-1.18%)
DVN : 37.31 (-0.48%)
MRO : 28.55 (-1.28%)
FANG : 155.23 (-0.57%)
CVX : 157.89 (+0.62%)
COP : 98.82 (+0.90%)
XOM : 111.27 (+0.52%)
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope

/PRNewswire/ -- USA News Group - Earlier this year, the US White House requested over $2.8 billion in funding from Congress for their "Cancer Moonshot"...

ONC.TO : 1.02 (-0.97%)
ONCY : 0.7138 (-1.63%)
IMGN : 31.23 (unch)
MRK : 91.27 (+1.98%)
AZN : 74.69 (+0.63%)
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – September 20, 2023 – USA News Group  –  Earlier this year, the US White House requested over $2.8 billion in funding from...

LLY : 881.40 (+0.88%)
RY : 118.57 (-0.26%)
RY.TO : 169.14 (-0.05%)
ONCY : 0.7138 (-1.63%)
ONC.TO : 1.02 (-0.97%)
IMGN : 31.23 (unch)
AZN : 74.69 (+0.63%)
MRK : 91.27 (+1.98%)
Markets Today: Stocks Push Higher on Strength in China and Europe

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.17%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.18% at a 1-week high. Stock indexes this morning are moderately...

ESH25 : 6,012.75 (+0.20%)
NQH25 : 21,431.00 (+0.05%)
COP : 98.82 (+0.90%)
DVN : 37.31 (-0.48%)
FANG : 155.23 (-0.57%)
XOM : 111.27 (+0.52%)
MRO : 28.55 (-1.28%)
SLB : 41.53 (-0.50%)
VLO : 135.06 (+0.24%)
MET : 81.21 (+0.25%)
PLTR : 90.68 (-10.53%)
ADBE : 444.42 (+0.02%)
ImmunoGen: Q2 Earnings Snapshot

ImmunoGen: Q2 Earnings Snapshot

IMGN : 31.23 (unch)
ImmunoBiochem Announces Multi-Target License and Option Agreement with ImmunoGen to Develop Next-Generation Antibody-Drug Conjugates

/PRNewswire/ - ImmunoBiochem Corporation, a privately-held biopharmaceutical company focused on the discovery of unique tumor targets and development of novel...

IMGN : 31.23 (unch)
MoonLake Immunotherapeutics Makes a Moonshot on Trials

Clinical-stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive clinical trial results.

MLTX : 40.96 (-3.24%)
IMGN : 31.23 (unch)
Five Top Companies Fighting for the Treatment of Metastatic Breast Cancer

A significant medical breakthrough is needed in the fight against metastatic breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of...

LLY : 881.40 (+0.88%)
PBYI : 2.89 (-0.52%)
GILD : 111.03 (+0.98%)
IMGN : 31.23 (unch)
BCTX : 4.54 (+2.71%)
BCT.TO : 6.45 (+1.90%)
ImmunoGen Stock Continues to Defy Gravity on Phase 2 Trials

ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles t

IMGN : 31.23 (unch)
C : 78.54 (-1.39%)
GILD : 111.03 (+0.98%)
LEA : 97.02 (+0.64%)
PFE : 26.65 (+1.33%)
SGEN : 228.74 (-0.07%)
AZN : 74.69 (+0.63%)
Stocks Settle Mixed on Weak U.S. Economic Reports

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.205%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.59%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed...

$SPX : 5,983.25 (-0.50%)
SPY : 597.21 (-0.46%)
$DOWI : 43,461.21 (+0.08%)
DIA : 434.53 (+0.09%)
$IUXX : 21,352.08 (-1.21%)
QQQ : 519.87 (-1.18%)
INTC : 24.27 (-2.41%)
GFS : 41.52 (-2.14%)
MRVL : 97.91 (-5.68%)
QCOM : 161.10 (-2.62%)
MCHP : 60.83 (-0.39%)
MU : 95.41 (-3.47%)
Stocks Slip in Afternoon Trade

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.2%. After...

$SPX : 5,983.25 (-0.50%)
SPY : 597.21 (-0.46%)
$DOWI : 43,461.21 (+0.08%)
DIA : 434.53 (+0.09%)
$IUXX : 21,352.08 (-1.21%)
QQQ : 519.87 (-1.18%)
DVN : 37.31 (-0.48%)
MRO : 28.55 (-1.28%)
FANG : 155.23 (-0.57%)
CVX : 157.89 (+0.62%)
COP : 98.82 (+0.90%)
XOM : 111.27 (+0.52%)

Barchart Exclusives

Warren Buffett Just Bought This Dividend Stock. Should You?
Constellation Brands, the maker of Corona and Modelo beers, has caught Warren Buffett’s attention with its strong fundamentals, dividend yield, and growth potential. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements